Evidence map›Paper›PMID 40858972›Full record

ArticleNature medicine2025

Publisher Correction: Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial.

Kari L Kendra, Shay L Bellasea, Zeynep Eroglu, Siwen Hu-Lieskovan, Katie M Campbell, William E Carson, David A Wada, Jose A Plaza, Jeffrey A Sosman, Gino K In and 23 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

33 authors.

Kari L KendraOhio State University Wexner Medical Center, Columbus, OH, USA. kari.kendra@osumc.edu.ORCID http://orcid.org/0000-0001-5936-6689
Shay L BellaseaSWOG Statistics and Data Management Center, Seattle, WA, USA.
Zeynep ErogluH. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Siwen Hu-LieskovanHuntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Katie M CampbellJonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0001-6491-4432
William E CarsonOhio State University Wexner Medical Center, Columbus, OH, USA.
David A WadaHuntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Jose A PlazaOhio State University Wexner Medical Center, Columbus, OH, USA.
Jeffrey A SosmanNorthwestern University, Chicago, IL, USA.
Gino K InNorris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
Alexandra IkeguchiUniversity of Oklahoma Stephenson Cancer Center, Oklahoma City, OK, USA.ORCID http://orcid.org/0000-0002-4448-9755
John HyngstromHuntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Andrew S BrohlH. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.ORCID http://orcid.org/0000-0002-0071-0534
Nikhil I KhushalaniH. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Joseph MarkowitzH. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
George NegreaLewis Cancer and Research Pavilion, Savannah, GA, USA.
Samer KasbariSoutheastern Medical Oncology Center, Goldsboro, NC, USA.
Gary C DoolittleUniversity of Kansas Cancer Center, Westwood, KS, USA.
Umang SwamiHuntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.ORCID http://orcid.org/0000-0003-3518-0411
Toni RobertsSaint Michael Cancer Center, Bremerton, WA, USA.
Boban N MathewMasonic Cancer Alliance, Freeman Cancer Center, Pittsburgh, PA, USA.
Egmidio MedinaJonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0002-3284-5329
Ignacio Baselga-CarreteroJonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA.
Cynthia R GonzalezJonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA.
Ivan Perez GarcilazoJonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA.
Agustin Vega-CrespoJonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA.
Jia Ming ChenJonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0003-3992-9143
Nataly Naser Al-DeenJonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA.
Sapna P PatelThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Elad SharonCancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
James MoonSWOG Statistics and Data Management Center, Seattle, WA, USA.
Michael C WuSWOG Statistics and Data Management Center, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-3357-6570
Antoni RibasJonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA. aribas@mednet.ucla.edu.ORCID http://orcid.org/0000-0003-3669-8458

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40858972

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.